Accumulating evidence has indicated the cGAS-STING pathway in driving neuroinflammation of neurodegenerative diseases, thus inhibition of this pathway represents a viable therapeutic in the treatment of neurodegenerative diseases. This evidence concerns the gene STING1 and neurodegenerative disease.